Skip to content

Guidewire, Model G-V220-3527S and Others

by Accellent, Inc.

510(k) K072354

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK072354 Date7 Dec 2007ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
OCY
Device Class
Class II
Regulation
21 CFR Part 876.1500
Advisory Committee
Gastroenterology, Urology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is an Endoscopic Guidewire, classified under the Gastroenterology-Urology specialty. It is designed to assist in the navigation and placement of endoscopic instruments within the biliary, pancreatic, or urinary tracts, providing structural support and guidance during procedures such as cholangiocarcinomarectomy, stent placement, or biopsy.

The Guidewire, Models G-V220-3527S and Others, is supplied as a single-use, non-sterile device for professional medical use. It is intended for use in controlled clinical settings, such as endoscopy suites or operating rooms, and must be handled under aseptic conditions. The device is classified as Class II under FDA regulation 876.1500 and holds an FDA 510(k) clearance (K072354) with a Substantially Equivalent (SESE) determination. Multiple model variants are listed under the product code OCY and are regulated for endoscopic applications in gastroenterology and urology.

Questions

AI-generated answers, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What medical specialties is this guidewire intended for, and how does it assist during procedures?

    This endoscopic guidewire is designed for use in gastroenterology and urology procedures. It provides structural support and guidance for navigating endoscopic instruments through the biliary, pancreatic, or urinary tracts. Common applications include assisting with cholangiocarcinomarectomy, stent placement, or biopsy, ensuring precise instrument placement during these interventions.

  • Is this guidewire single-use or reusable, and what does that mean for handling in a clinical setting?

    The guidewire is single-use only, meaning it is intended for one-time use in a controlled clinical environment like an endoscopy suite or operating room. Since it is supplied non-sterile, it must be handled under aseptic conditions before use, typically involving sterilization by the facility prior to procedure. This ensures patient safety and prevents cross-contamination.

  • How do I determine which model variant is right for my procedure, and are there multiple sizes available?

    The device comes in multiple model variants, each listed under the product code OCY and regulated for endoscopic use in gastroenterology and urology. While the exact specifications (e.g., length, diameter, or flexibility) are not detailed here, the manufacturer offers a range of options to accommodate different procedural needs. For precise sizing, refer to the product documentation or contact Accellent, Inc. directly, as the variants are tailored for specific applications like biliary or urinary tract navigation.

  • What regulatory pathway was followed for this device, and what does that mean for its use in clinical practice?

    This guidewire received FDA 510(k) clearance (K072354) with a Substantially Equivalent (SESE) determination, meaning it was deemed comparable to a legally marketed predicate device. It is classified as Class II under FDA regulation 876.1500, indicating it undergoes stringent review for safety and effectiveness. Clinically, this clearance confirms the device meets FDA standards for use in endoscopic procedures, but facilities should still follow local protocols and ensure proper training for staff.